Centessa Pharmaceuticals plc
CNTADelisted Jun 24, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001847903
Centessa Pharmaceuticals plc was delisted on Jun 24, 2026; its insiders filed their last Form 4 on Jun 24, 2026; 161 institutions reported holding it in 13F filings for Q1 2026, worth $5.90B in total; Maverick Capital was the only superinvestor holding it.
13F holders, Q1 2026
Institutional positions in Centessa Pharmaceuticals plc as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
CNTA is no longer listed, so this page shows Q1 2026. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 161
- +15 vs. Q4 2025
- Shares held
- 148.6M
- +4.87M (+3.4%) vs. Q4 2025
- Total value
- $5.90B
- +$2.30B (+64.0%) vs. Q4 2025
- New holders
- 48
- 50 more added
- Sold out
- 33
- 45 more reduced
1 institution that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNTA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 161 | $5.90B |
| Q4 2025 | 147 | $3.60B |
| Q3 2025 | 125 | $3.11B |
| Q2 2025 | 117 | $1.62B |
| Q1 2025 | 130 | $1.80B |
| Q4 2024 | 114 | $2.08B |
| Q3 2024 | 103 | $1.74B |
| Q2 2024 | 80 | $781.2M |
| Q1 2024 | 69 | $840.7M |
| Q4 2023 | 58 | $567.4M |
| Q3 2023 | 49 | $469.6M |
| Q2 2023 | 45 | $435.4M |
| Q1 2023 | 44 | $257.5M |
| Q4 2022 | 44 | $194.4M |
| Q3 2022 | 44 | $288.7M |
| Q2 2022 | 41 | $350.3M |
| Q1 2022 | 44 | $669.1M |
| Q4 2021 | 47 | $807.8M |
| Q3 2021 | 40 | $947.5M |
| Q2 2021 | 50 | $1.05B |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Centessa Pharmaceuticals plc; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| TD Asset Management Inc | 242,044 | $9.61M | 0.01% | −134,300−35.7% | Reduced |
| Nantahala Capital Management, LLC | 254,803 | $10.1M | 0.63% | 00.0% | Unchanged |
| Caption Management, LLC | 274,116 | $10.9M | 0.52% | +274,116 | New |
| Royce & Associates LP | 278,064 | $11.0M | 0.11% | −84,809−23.4% | Reduced |
| Point72 Asset Management, L.P. | 307,355 | $12.2M | 0.02% | +307,355 | New |
| Alyeska Investment Group, L.P. | 320,430 | $12.7M | 0.04% | +320,430 | New |
| Glazer Capital, LLC | 325,001 | $12.9M | 0.27% | +325,001 | New |
| JPMorgan Chase & Co | 477,597 | $13.2M | 0.00% | +396,111+486.1% | Added |
| Rock Springs Capital Management LP | 351,828 | $14.0M | 0.82% | +27,813+8.6% | Added |
| UBS Group AG | 359,939 | $14.3M | 0.00% | −177,579−33.0% | Reduced |
| Trexquant Investment LP | 390,951 | $15.5M | 0.11% | +244,428+166.8% | Added |
| Silverarc Capital Management, LLC | 466,345 | $18.5M | 2.18% | +8,142+1.8% | Added |
| Spruce Street Capital LP | 489,849 | $19.5M | 4.68% | +411,852+528.0% | Added |
| Weiss Asset Management LP | 510,407 | $20.3M | 0.37% | +510,407 | New |
| PFM Health Sciences, LP | 528,224 | $21.0M | 2.21% | −63,377−10.7% | Reduced |
| 5AM Venture Management, LLC | 580,945 | $23.1M | 6.41% | 00.0% | Unchanged |
| Citadel Advisors LLC | 598,197 | $23.8M | 0.02% | +78,235+15.0% | Added |
| BlackRock, Inc. | 625,420 | $24.8M | 0.00% | +32,816+5.5% | Added |
| Qube Research & Technologies Ltd | 628,049 | $24.9M | 0.04% | +249,309+65.8% | Added |
| Bain Capital Life Sciences Investors, LLC | 635,000 | $25.2M | 2.27% | +635,000 | New |
| D. E. Shaw & Co., Inc. | 643,808 | $25.6M | 0.02% | −187,828−22.6% | Reduced |
| TIG Advisors, LLC | 648,326 | $25.8M | 1.23% | +648,326 | New |
| Toronto Dominion Bank | 654,850 | $26.0M | 0.05% | +654,850 | New |
| Eventide Asset Management, LLC | 668,142 | $26.5M | 0.44% | +668,142 | New |
| Baker Bros. Advisors LP | 670,751 | $26.6M | 0.15% | 00.0% | Unchanged |
| Franklin Resources Inc | 684,482 | $27.2M | 0.01% | −1,683,899−71.1% | Reduced |
| American Century Companies Inc | 687,427 | $27.3M | 0.01% | −442,331−39.2% | Reduced |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 702,254 | $27.9M | 0.03% | +702,254 | New |
| Millennium Management LLC | 722,121 | $28.7M | 0.02% | −1,148,550−61.4% | Reduced |
| Octagon Capital Advisors LP | 750,000 | $29.8M | 3.30% | 00.0% | Unchanged |
| Balyasny Asset Management LLC | 852,828 | $33.9M | 0.07% | +384,013+81.9% | Added |
| Woodline Partners LP | 859,105 | $34.1M | 0.13% | +280,854+48.6% | Added |
| Alpine Associates Management Inc. | 865,500 | $34.4M | 2.03% | +865,500 | New |
| Cormorant Asset Management, LP | 1,050,000 | $41.7M | 2.10% | −275,000−20.8% | Reduced |
| Siren, L.L.C. | 1,053,464 | $41.8M | 1.16% | −2,974,053−73.8% | Reduced |
| Goldman Sachs Group Inc | 1,144,560 | $45.5M | 0.01% | +365,559+46.9% | Added |
| General Atlantic LLC | 1,354,830 | $53.8M | 2.50% | −4,762,885−77.9% | Reduced |
| Foresite Capital Management VI LLC | 1,364,019 | $54.2M | 11.77% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 1,400,000 | $55.6M | 3.26% | +799,448+133.1% | Added |
| First Light Asset Management, LLC | 1,560,991 | $62.0M | 5.56% | −717,949−31.5% | Reduced |
| Maverick Capital LtdSuperinvestorMaverick Capital | 1,854,488 | $73.7M | 0.86% | +210,764+12.8% | Added |
| Bank of America Corp | 1,932,406 | $76.8M | 0.01% | +982,862+103.5% | Added |
| Braidwell LP | 1,986,768 | $78.9M | 2.63% | −201,552−9.2% | Reduced |
| Federated Hermes, Inc. | 2,049,439 | $81.4M | 0.13% | −292,700−12.5% | Reduced |
| RTW Investments, LP | 2,054,175 | $81.6M | 0.81% | +263,338+14.7% | Added |
| Logos Global Management LP | 2,125,000 | $84.4M | 4.35% | +1,925,000+962.5% | Added |
| Deep Track Capital, LP | 3,158,041 | $125.4M | 2.59% | +1,158,041+57.9% | Added |
| Janus Henderson Group PLC | 3,492,977 | $138.7M | 0.07% | −600,631−14.7% | Reduced |
| Paradigm Biocapital Advisors LP | 3,574,048 | $142.0M | 2.90% | +3,574,048 | New |
| Morgan Stanley | 4,268,353 | $169.5M | 0.01% | +3,159,255+284.8% | Added |
| TCG Crossover Management, LLC | 4,286,480 | $170.3M | 4.87% | 00.0% | Unchanged |
| Farallon Capital Management, L.L.C. | 4,809,000 | $191.0M | 1.13% | −568,068−10.6% | Reduced |
| Capital World Investors | 4,832,548 | $191.9M | 0.03% | +3,673,849+317.1% | Added |
| Perceptive Advisors LLC | 5,258,903 | $208.9M | 4.13% | +2,341,269+80.2% | Added |
| EcoR1 Capital, LLC | 6,000,000 | $238.3M | 10.19% | +2,885,000+92.6% | Added |
| FMR LLC | 6,852,047 | $272.2M | 0.01% | −2,109,892−23.5% | Reduced |
| Pentwater Capital Management LP | 8,170,000 | $324.5M | 2.31% | +8,170,000 | New |
| Adage Capital Partners GP, L.L.C. | 8,925,010 | $354.5M | 0.55% | −2,356,731−20.9% | Reduced |
| Index Venture Life Associates VI Ltd | 9,961,789 | $395.7M | 100.00% | 00.0% | Unchanged |
| Avoro Capital Advisors LLC | 11,430,455 | $454.0M | 4.47% | −3,125,100−21.5% | Reduced |
| Medicxi Ventures Management (Jersey) Ltd | 19,963,157 | $792.9M | 80.76% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −3,927,343−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −1,154,114−100.0% | Sold out |
| Sofinnova Investments, Inc. | 0 | $0 | 0.00% | −1,104,274−100.0% | Sold out |
| Commodore Capital LP | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −500,000−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −441,160−100.0% | Sold out |
| Saturn V Capital Management LLC | 0 | $0 | 0.00% | −282,692−100.0% | Sold out |
| WCM Investment Management, LLC | 0 | $0 | 0.00% | −257,190−100.0% | Sold out |
| Blue Owl Capital Holdings LP | 0 | $0 | 0.00% | −139,450−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −121,810−100.0% | Sold out |
| Rhenman & Partners Asset Management AB | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −94,912−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −90,000−100.0% | Sold out |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 0 | $0 | 0.00% | −81,525−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −79,077−100.0% | Sold out |
| Wellington Management Group LLP | 0 | $0 | 0.00% | −50,180−100.0% | Sold out |
| Seven Grand Managers, LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Persistent Asset Partners Ltd | 0 | $0 | 0.00% | −43,266−100.0% | Sold out |
| B. Metzler seel. Sohn & Co. AG | 0 | $0 | 0.00% | −38,432−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −33,104−100.0% | Sold out |
| PSP Research LLC | 0 | $0 | 0.00% | −21,879−100.0% | Sold out |
| Campbell & CO Investment Adviser LLC | 0 | $0 | 0.00% | −16,243−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −12,569−100.0% | Sold out |
| Oxford Asset Management LLP | 0 | $0 | 0.00% | −11,166−100.0% | Sold out |
| Sigma Planning Corp | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −8,496−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −3,468−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −294−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| Flagship Harbor Advisors, LLC | 0 | $0 | 0.00% | −200−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −174−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |